MOCA enters into partnership with Sementi, one of Europe’s largest livestock feed producers. The equal equity partnership between Medicinal Organic Cannabis Australia (MOCA) Pty Ltd of Sydney Australia and Italian Sementi Srl is created to manufacture a range of medical cannabis based feed supplements for high value livestock. The new product range will include a cannabinoid formula developed by MOCA and will be sold under the MOCA CBD brand and will enter into the market for distribution in December 2020.

 

MOCA is very pleased to announce its partnership with Sementi. Cannabis medication for humans is growing rapidly around the world and we are proud to be at the forefront. We are at the very beginning of CBD for animals and are proud to be pioneering with an industry leader into this new sector that is destined to grow to over US$200 billion

said MOCA co-founder and Managing Director Alessandro Sorbello.

 

Science has taken significant steps forward in determining the positive effects of CBD and other cannabinoids found in cannabis. Starting with the discovery in 1990 that all animals with a vertebrae have an endocannabinoid system that responds very well to cannabinoids like CBD and CBG, present in the cannabis plant. Scientific studies show that CBD oil is proving to not only treat common health conditions, but also help to prevent them from developing or worsening. Among other uses for treating animals it is very effective in stimulating appetite, reduces anxiety, pain management and aids recovering from injuries.

MOCA is currently raising money from the general public to fund expanding their product range and importing affordable organic cannabis medicine for the Australian market. The equity crowd share campaign is now live until the 21st of October or until fully subscribed.

Mr Sorbello’s science based team has been working with cannabinoids for the past 3 years to develop MOCA’s product range. “Our team focused on a commonality amongst a vast majority of health issues and found that they all have one major thing in common. Inflammation is at the root of nearly every disease that both people and our animals face. From cancer to allergies, inflammation is to blame. Therefore, reducing inflammation is paramount not only in providing relief for current health issues but also to prevent diseases from developing in the future. CBD oil is an all natural anti-inflammatory. Countless studies show that it is able to reduce present inflammation and is a key factor in preventing the development and spreading of inflammation“.

MOCA believes that the animal and pet market is set to grow exponentially as the health benefits become more known and promoted. Sorbello says “that partnering with Sementi makes us extremely well positioned to become market leaders in this new cannabis based nutraceutical product designed for high value animals throughout Europe“.

 

About Medicinal Organic Cannabis Australia (MOCA) Pty Ltd

Founded in 2017, MOCA is a fully licensed medical cannabis import/export and wholesaler based in Sydney Australia. The company is led by Alessandro Sorbello and has developed a range of 21 products approved by the TGA for Australian patients. MOCA works extensively with cultivators to ensure product quality and have developed an innovative product that will drastically reduce patient access costs. Their CBD infused tea will be in Australia ready for prescription in December 2020 and will drastically reduce the price below black market prices.

About Sementi

Sementi owner is a passionate breeder of Arabian racehorses and many of his horses have run in the famous Palio di Siena. Sementi, was established in 1980 and produces feed for all animals with a focus on agricultural livestock. The company has an annual turnover of AUD$20million and has been growing at a rate of 30% per annum in gross sales. They are on target to reach their manufacturing output of 100,000 tonnes of products per year. Currently Sementi distributes its products throughout Europe with a strong focus in the Mediterranean region.